a Asuragen, Inc , Austin , TX , USA.
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):107-114. doi: 10.1080/21678421.2018.1522353. Epub 2018 Nov 15.
Expansion of the GC repeat tract in the C9orf72 gene is linked to frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). Here, we provide comprehensive genotyping of the C9orf72 repeat region for the National Institute of Neurological Disorders and Stroke (NINDS) ALS collection (n = 2095), using a novel bimodal PCR assay capable of amplifying nearly 100% GC-rich sequences.
A single-tube 3-primer PCR assay mode, resolved using capillary electrophoresis, was used for sizing up to 145 repeats with single-repeat accuracy, for detecting expansions irrespective of their overall size, and for flagging confounding 3' sequence variations (SVs). A modified two-primer PCR mode, resolved via agarose gel electrophoresis, provided further size information for hyper-expanded samples (>145 repeats) up to ∼5.8 kb amplicons (∼950 GC repeats).
Within the evaluated cohort, 177 (8.4%) samples were expanded, with 175 (99%) samples being hyper-expanded. 3'-SVs were identified in 64 (3.1%) samples, and were most common in expanded alleles. Genotypes of all 606 (29%) homozygous samples were confirmed using an orthogonal PCR assay.
This study and PCR method may improve and standardize molecular characterization of the C9orf72 locus, and have the potential to inform phenotype-genotype correlations and therapeutic development in ALS/FTD.
C9orf72 基因中的 GC 重复序列扩张与额颞叶痴呆(FTD)和肌萎缩侧索硬化症(ALS)有关。在这里,我们使用一种新型的双模式 PCR 检测方法,对国立神经病学与卒中研究所(NINDS)ALS 样本集(n=2095)中的 C9orf72 重复区域进行了全面的基因分型,该方法能够扩增近 100%的 GC 丰富序列。
使用单管 3 引物 PCR 检测方法,通过毛细管电泳进行解析,可对多达 145 个重复进行单重复精度的大小测定,用于检测扩展,而不考虑其总体大小,并标记混杂的 3'序列变异(SVs)。改良的双引物 PCR 模式,通过琼脂糖凝胶电泳进行解析,为大于 145 个重复的超扩展样本提供了进一步的大小信息,最长可达约 5.8kb 片段(约 950 GC 重复)。
在所评估的队列中,有 177 个(8.4%)样本发生了扩展,其中 175 个(99%)样本发生了超扩展。在 64 个(3.1%)样本中发现了 3'-SVs,并且在扩展等位基因中最常见。使用正交 PCR 检测方法对所有 606 个(29%)纯合样本的基因型进行了确认。
本研究和 PCR 方法可能改善和标准化 C9orf72 基因座的分子特征,并有可能为 ALS/FTD 中的表型-基因型相关性和治疗开发提供信息。